+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Lung Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Lung Cancer Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 171 Pages
  • Global
From
From
Kidney Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Kidney Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
US Biosimilar industry outlook to 2028 - Product Thumbnail Image

US Biosimilar industry outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Royalty Rates in Pharmaceutical and Biotechnology Deals - Product Thumbnail Image

Royalty Rates in Pharmaceutical and Biotechnology Deals

  • Report
  • August 2024
  • 500 Pages
  • Global
From
Cancer Supportive Care - Global Strategic Business Report - Product Thumbnail Image

Cancer Supportive Care - Global Strategic Business Report

  • Report
  • November 2024
  • 262 Pages
  • Global
From
From
From
From
From
From
Metastatic Renal Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Renal Cell Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 170 Pages
  • Global
From
Global Biosimilars Market 2020-2025 - Product Thumbnail Image

Global Biosimilars Market 2020-2025

  • Report
  • May 2021
  • 358 Pages
  • Global
From
Loading Indicator